Promising Results for Aneurysm Device

Published date : 20 September 2012
Article date : 20 September 2012

Masshightech reports that medical device developer, Codman & Shutlef has seen positive results for its Vascular Reconstruction Device (VRD), a self-expanding stent used in patients with wide neck saccular aneurysms. 

They say that data published in Neurosurgery showed 81% of patients had 90% or higher aneurysm closure after 21 months and only 8.3% required retreatment after stent-assisted coil embolization with Codman’s VRD. The registry included data of 229 patients from 9 neurointerventional centers including the University of Florida, Albany Medical Center Hospital, Capital Health System, University of Texas Southwestern and Mayo Clinic. 

32 of the patients had ruptured aneurysms. On average, patients were 57 years old at the time of treatment and had a 9.2 millimeter aneurysm. Apparently, the data also showed that 90% of patients had modified Rankin Scale scores of 2 or less. The mRS score, measuring the degree of disability in daily activities, showed no significant disabilities nearly 2 years after treatment with the device. 

Source: By Patricia Resende,, 17 September 2012

Read the full article here.

Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.